Citizens line up to take new coronavirus tests at a temporary screening center in Seoul on April 25, 2021. (Yonhap)
SEOUL, April 25 (Korea Bizwire) — South Korea’s daily new virus cases fell below 700 for the first time in five days on Sunday due to fewer tests during the weekend, amid lingering concerns about a fourth wave of COVID-19 infections.
The country reported 644 more COVID-19 cases, including 603 local infections, raising the total caseload to 118,887, the Korea Disease Control and Prevention Agency (KDCA) said. The country added one more death, raising the total to 1,813.
The daily infections neared 800 last week as cluster infections continued to emerge nationwide. Untraceable cases accounted for about 30 percent of all cases reported in the past two weeks, the highest ever.
The reproduction rate stood at 2.94, it said, which means a single COVID-19 patient transmits the disease to almost three people. A day ago, the rate was 1.59 percent.
The greater Seoul area where more than half of the country’s 52 million people reside is under Level 2 social distancing, the third highest in the five-tier scheme, with the rest of the country under Level 1.5.
The current social distancing level will be effective till May 2, while private gatherings of five or more people are banned nationwide.
As of 9 p.m. Sunday, health authorities and local governments had reported 463 new COVID-19 cases, down 122 from the same time Saturday, mainly due to fewer tests during the weekend.
Health authorities warned of tougher rules on multiuse facilities and business operations, as well as an additional ban on gatherings, if the current infection trend continues.
The KDCA said it will designate one week starting Monday as a special quarantine period to stop the current pace of the outbreak.
Dining-in by civil servants will be banned, and working from home as well as working half the time or part of business hours will be expanded in the public sector, the authorities said.
A medical worker conducts a COVID-19 test on a woman at a makeshift testing booth in Seoul on April 25, 2021. (Yonhap)
On Saturday, South Korea said it has signed a deal with U.S. pharmaceutical giant Pfizer Inc. to import additional vaccines for 20 million people.
The latest deal raised the total number of COVID-19 vaccine doses from the World Health Organization’s global vaccine COVAX Facility project and pharmaceutical companies to an amount enough to inoculate 99 million people.
Health authorities aim to create herd immunity by November by . The country started its inoculation campaign in late February.
As of midnight Saturday, 2,260,639 people, or 4.4 percent of the population, had received one dose of the COVID-19 vaccine, up 64,344 from a day earlier, with 104,538 people, or 0.2 percent of the population, vaccinated with two doses, up 5,769 from a day ago.
AstraZeneca’s vaccine took up 1,311,996, while Pfizer’s accounted for 948,643, according to the KDCA.
A total of 13,529 cases of side effects after vaccinations have been reported, though 13,285 of them were mild symptoms.
A total of 58 deaths after vaccinations have been reported, according to the KDCA.
There are currently 204 injection centers nationwide, but the country plans to open an additional 53 centers next Thursday to speed up vaccinations.
Of the newly confirmed locally transmitted cases, 172 came from Seoul, 187 form Gyeonggi Province and 15 from Incheon, 40 kilometers west of the capital.
The southeastern port city of Busan, the country’s second-largest city, reported 43 more cases.
The total number of people released from quarantine after making full recoveries was 108,475, up 694 from a day earlier.
(Yonhap)
